Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Doxycycline)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST003066 AN005022 Heritability of RBC metabolites: baseline correlation of metabolites and markers of RBC health and stability Erythrocytes Human University of Iowa area under curve
ST001639 AN002681 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST003365 AN005515 Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003366 AN005517 Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro Synthetic Other Cancer Wistar Institute Counts per second (cps)
ST003367 AN005519 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003411 AN005603 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003412 AN005605 Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003427 AN005627 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate Breast cancer cells Human Cancer Wistar Institute Counts per second (cps)
ST003427 AN005628 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate Breast cancer cells Human Cancer Wistar Institute Counts per second (cps)
ST003428 AN005629 Intracellular and medium metabolomics of BT-474 cells treated with rotenone Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003428 AN005630 Intracellular and medium metabolomics of BT-474 cells treated with rotenone Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003429 AN005632 Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003430 AN005634 Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003431 AN005636 Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003432 AN005638 Intracellular and medium metabolomics of BT-474 cells treated with LW6 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003433 AN005640 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 Cultured cells Human Cancer Wistar Institute Counts per second (cps)
ST003434 AN005642 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Human Cancer Wistar Institute Counts per second (cps)
ST003435 AN005644 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media, Metabolite extract Zebra fish Cancer Wistar Institute Counts per second (cps)
ST003436 AN005646 Pharmacokinetics of Fasnall in NSG mice Brain, Heart, Liver, Blood Mouse Cancer Wistar Institute Counts per second (cps)
ST002498 AN004655 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST003520 AN005779 Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis Blood Human Arthritis University of Kansas Peak area
ST001400 AN002340 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria Blood Human Malaria New York University Abu Dhabi raw area counts
ST001516 AN002515 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) Blood Human Malaria New York University Abu Dhabi raw area counts
ST002819 AN004591 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002088 AN003406 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003411 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST000093 AN000148 Metabolomics Analysis of Frontal Fibrosing Alopecia Scalp Human Alopecia Case Western Reserve University Unspecified
  logo